Hepatitis A, B, C, D, E, G: an update

Gairy F Hall1

  • 1University Health Department, Northeastern University, Boston, Massachusetts, USA. g.hall@neu.edu

Ethnicity & Disease
|August 9, 2007
PubMed

Insights

This review covers viral hepatitis, including types A through G, focusing on their epidemiology, symptoms, diagnosis, treatment, and prevention strategies for clinicians. Understanding these viral liver diseases is crucial for effective patient management and public health.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Liver diseases present with abnormal liver function tests or clinical signs.
  • Differential diagnosis includes primary and secondary liver involvement.
  • Viral hepatitis represents a significant global health burden.

Purpose of the Study:

  • To provide a comprehensive overview of viral hepatitis types A, B, C, D, E, and G.
  • To detail the epidemiology, clinical manifestations, and diagnostic approaches for each viral hepatitis type.
  • To outline current treatment and prevention strategies for viral liver diseases.

Main Methods:

  • Literature review of viral hepatitis A-G.
  • Synthesis of epidemiological data.
  • Summary of clinical presentation and diagnostic criteria.
  • Review of therapeutic interventions and preventative measures.

Main Results:

  • Each viral hepatitis type (A-G) exhibits distinct epidemiological patterns and clinical courses.
  • Accurate diagnosis relies on specific serological markers and clinical evaluation.
  • Effective treatments and preventative measures, including vaccination and antiviral therapies, are available for several types.

Conclusions:

  • Viral hepatitis encompasses a spectrum of liver diseases requiring tailored management.
  • Early diagnosis and appropriate intervention are key to improving patient outcomes.
  • Public health initiatives focusing on prevention and vaccination are essential for controlling viral hepatitis spread.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...